Literature DB >> 10901172

Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells.

S W Kang1, H Kang, I S Park, S H Choi, K H Shin, Y S Chun, B G Chun, B H Min.   

Abstract

We purified and partially sequenced a cytostatic protein from the ASC-17D Sertoli cell-conditioned media (rSCCM) showing a molecular weight of 90 kDa with homodimeric composition. N-terminal amino acid analysis revealed that the protein was homologous to the arginine deiminase (ADI) of Mycoplasma arginini. We found ADI enzyme activity in rSCCM and the abolishment of the growth inhibitory effect by the supplement of L-arginine. Thus, we confirmed that the cytostatic activity in rSCCM was due to the depletion of extracellular L-arginine by ADI. Apparent increase of cell death or DNA fragmentation was not observed in DU145 cells cultured in the presence of ADI. Incubation of DU145 cancer cells with taxol resulted in a marked DNA fragmentation, whereas pretreatment with ADI or cycloheximide protected the cells from taxol-induced apoptosis. Preincubation of the cells with ADI inhibited S35-methionine incorporation into protein synthesis in a dose dependent manner. These data suggest that ADI-induced arginine depletion may inhibit protein synthesis, and result in the protection of apoptotic cell death that requires new protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901172

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  3 in total

Review 1.  Arginine deprivation as a targeted therapy for cancer.

Authors:  L Feun; M You; C J Wu; M T Kuo; M Wangpaichitr; S Spector; N Savaraj
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

2.  Extrinsic nitric oxide donor partially reverses arginine deiminase induced cell growth inhibition through NFkappaB and Bcl-X L.

Authors:  Jae Hong Seo; Hwa Jung Sung; Chul Won Choi; Byung Soo Kim; Sang Won Shin; Yeul Hong Kim; Bon Hong Min; Jun Suk Kim
Journal:  Invest New Drugs       Date:  2008-01-05       Impact factor: 3.850

3.  Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth.

Authors:  I-S Park; S-W Kang; Y-J Shin; K-Y Chae; M-O Park; M-Y Kim; D N Wheatley; B-H Min
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.